CAR--话题@MedSci

#CAR-#

459篇内容 | 2265人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781417, encodeId=324f1e814172e, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Med：多发性骨髓瘤患者在BCMA靶向CAR-T治疗后或引起BCMA纯合缺失, objectType=article, longId=207579, objectId=380720e5793a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=380720e5793a, replyNumber=0, likeNumber=67, createdTime=2021-11-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=380720e5793a, moduleTitle=Nat Med：多发性骨髓瘤患者在BCMA靶向CAR-T治疗后或引起BCMA纯合缺失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=380720e5793a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781418, encodeId=41111e814184d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：BCMA靶向CAR-T细胞疗法Idecabtagene Vicleucel（Ide-cel）取得积极结果, objectType=article, longId=207624, objectId=eba320e6248f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eba320e6248f, replyNumber=0, likeNumber=74, createdTime=2021-11-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eba320e6248f, moduleTitle=NEJM：BCMA靶向CAR-T细胞疗法Idecabtagene Vicleucel（Ide-cel）取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eba320e6248f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781378, encodeId=e8a21e8137801, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=同种异体CAR-T细胞疗法治疗白血病，获得FDA的快速通道指定, objectType=article, longId=199754, objectId=3106199e5420, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3106199e5420, replyNumber=0, likeNumber=54, createdTime=2020-12-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3106199e5420, moduleTitle=同种异体CAR-T细胞疗法治疗白血病，获得FDA的快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3106199e5420)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781407, encodeId=78be1e81407f1, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Sci Tran Med：CAR-T新开关——来那度胺 | Science子刊全新成果, objectType=article, longId=206268, objectId=2e142062680b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e142062680b, replyNumber=0, likeNumber=69, createdTime=2021-05-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e142062680b, moduleTitle=Sci Tran Med：CAR-T新开关——来那度胺 | Science子刊全新成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e142062680b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781385, encodeId=b6881e8138561, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：靶向细胞因子检查点可增强脐带血CAR-NK细胞的适应性, objectType=article, longId=201063, objectId=c4a320106355, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a320106355, replyNumber=0, likeNumber=60, createdTime=2020-12-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a320106355, moduleTitle=Blood：靶向细胞因子检查点可增强脐带血CAR-NK细胞的适应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a320106355)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781383, encodeId=6cb21e81383b4, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=国内申报上市的第二个CAR-T疗法获“优先审评+突破性药物”双重审评资格, objectType=article, longId=200548, objectId=626120054831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=626120054831, replyNumber=0, likeNumber=95, createdTime=2021-06-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=626120054831, moduleTitle=国内申报上市的第二个CAR-T疗法获“优先审评+突破性药物”双重审评资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=626120054831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781400, encodeId=9e771e81400b1, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=北京发布《CAR-T细胞免疫疗法临床研究伦理审查指南》, objectType=article, longId=205468, objectId=b398205468c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b398205468c7, replyNumber=0, likeNumber=74, createdTime=2021-10-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b398205468c7, moduleTitle=北京发布《CAR-T细胞免疫疗法临床研究伦理审查指南》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b398205468c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781384, encodeId=a2d31e81384b7, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=沉默IL-6表达！优卡迪创新型CAR-T产品获批临床, objectType=article, longId=200549, objectId=dd6320054969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd6320054969, replyNumber=0, likeNumber=72, createdTime=2021-02-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd6320054969, moduleTitle=沉默IL-6表达！优卡迪创新型CAR-T产品获批临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd6320054969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781387, encodeId=de8f1e813874c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=FDA授予CAR-T癌症疗法CLBR001 + SWI019“快速通道称号”, objectType=article, longId=201505, objectId=49a62015058d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49a62015058d, replyNumber=0, likeNumber=61, createdTime=2021-01-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49a62015058d, moduleTitle=FDA授予CAR-T癌症疗法CLBR001 + SWI019“快速通道称号”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49a62015058d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781386, encodeId=46411e8138655, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell：CAR-T疗法神经毒性危害大？全新Cell揭秘关键突破口！, objectType=article, longId=201187, objectId=d7e520118e1d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e520118e1d, replyNumber=0, likeNumber=63, createdTime=2020-12-12, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e520118e1d, moduleTitle=Cell：CAR-T疗法神经毒性危害大？全新Cell揭秘关键突破口！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e520118e1d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781353, encodeId=a6311e81353a5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：CAR-NK细胞治疗在血液肿瘤中疗效亮眼！, objectType=article, longId=191067, objectId=50d819106e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50d819106e1f, replyNumber=0, likeNumber=80, createdTime=2020-08-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50d819106e1f, moduleTitle=NEJM：CAR-NK细胞治疗在血液肿瘤中疗效亮眼！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50d819106e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781345, encodeId=81831e813450e, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T耐药谁之过？T细胞or癌细胞？, objectType=article, longId=187451, objectId=e11818e451a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e11818e451a1, replyNumber=0, likeNumber=71, createdTime=2020-05-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e11818e451a1, moduleTitle=CAR-T耐药谁之过？T细胞or癌细胞？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e11818e451a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781349, encodeId=5b351e8134951, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=国内CAR-T新药上市申请获受理！, objectType=article, longId=188939, objectId=9ba31889397c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ba31889397c, replyNumber=0, likeNumber=74, createdTime=2020-12-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ba31889397c, moduleTitle=国内CAR-T新药上市申请获受理！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ba31889397c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781367, encodeId=91a11e813673a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：精氨酸合成“buff”增强了CAR-T细胞的增殖和抗肿瘤疗效, objectType=article, longId=196675, objectId=5e791966e59e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e791966e59e, replyNumber=0, likeNumber=83, createdTime=2020-12-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e791966e59e, moduleTitle=Blood：精氨酸合成“buff”增强了CAR-T细胞的增殖和抗肿瘤疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e791966e59e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781360, encodeId=99951e81360b5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=强生的CAR-T疗法JNJ-4528用于多发性骨髓瘤：86%的患者获得完全缓解, objectType=article, longId=194235, objectId=88cf19423508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88cf19423508, replyNumber=0, likeNumber=80, createdTime=2020-12-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88cf19423508, moduleTitle=强生的CAR-T疗法JNJ-4528用于多发性骨髓瘤：86%的患者获得完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88cf19423508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781380, encodeId=10ba1e8138004, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=GMP级慢病毒载体制备CAR-T细胞治疗之进展及未来, objectType=article, longId=199863, objectId=fd06199863f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd06199863f5, replyNumber=0, likeNumber=71, createdTime=2021-04-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd06199863f5, moduleTitle=GMP级慢病毒载体制备CAR-T细胞治疗之进展及未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd06199863f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781357, encodeId=85f11e813572c, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, objectType=article, longId=193184, objectId=fb6d193184c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6d193184c5, replyNumber=0, likeNumber=62, createdTime=2020-11-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6d193184c5, moduleTitle=AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6d193184c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781389, encodeId=0eea1e81389d7, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Med ：免疫疗法新突破！人体实验数据揭示CAR-NKT疗法治疗实体瘤的潜力, objectType=article, longId=202391, objectId=ca552023914f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca552023914f, replyNumber=0, likeNumber=59, createdTime=2021-03-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca552023914f, moduleTitle=Nat Med ：免疫疗法新突破！人体实验数据揭示CAR-NKT疗法治疗实体瘤的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca552023914f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781381, encodeId=80eb1e81381cc, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Med ：新型双CAR-T细胞疗法，快速清除体内HIV病毒，持久保护, objectType=article, longId=200191, objectId=d92e20019135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d92e20019135, replyNumber=0, likeNumber=85, createdTime=2021-07-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d92e20019135, moduleTitle=Nat Med ：新型双CAR-T细胞疗法，快速清除体内HIV病毒，持久保护, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d92e20019135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781377, encodeId=190a1e813771d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=EXUMA公司的rPOC平台让CAR-T细胞治疗插上翅膀, objectType=article, longId=199563, objectId=f8f8199563ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8f8199563ac, replyNumber=0, likeNumber=76, createdTime=2020-09-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8f8199563ac, moduleTitle=EXUMA公司的rPOC平台让CAR-T细胞治疗插上翅膀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8f8199563ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nat Med：多发性骨髓瘤患者在BCMA靶向CAR-T治疗后或引起BCMA纯合缺失

2021-11-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：BCMA靶向CAR-T细胞疗法Idecabtagene Vicleucel（Ide-cel）取得积极结果

2021-11-16

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

同种异体CAR-T细胞疗法治疗白血病，获得FDA的快速通道指定

2020-12-12

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Sci Tran Med：CAR-T新开关——来那度胺 | Science子刊全新成果

2021-05-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Blood：靶向细胞因子检查点可增强脐带血CAR-NK细胞的适应性

2020-12-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

国内申报上市的第二个CAR-T疗法获“优先审评+突破性药物”双重审评资格

2021-06-13

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

北京发布《CAR-T细胞免疫疗法临床研究伦理审查指南》

2021-10-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

沉默IL-6表达！优卡迪创新型CAR-T产品获批临床

2021-02-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

FDA授予CAR-T癌症疗法CLBR001 + SWI019“快速通道称号”

2021-01-20

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell：CAR-T疗法神经毒性危害大？全新Cell揭秘关键突破口！

2020-12-12

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：CAR-NK细胞治疗在血液肿瘤中疗效亮眼！

2020-08-13

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T耐药谁之过？T细胞or癌细胞？

2020-05-18

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

国内CAR-T新药上市申请获受理！

2020-12-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Blood：精氨酸合成“buff”增强了CAR-T细胞的增殖和抗肿瘤疗效

2020-12-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

强生的CAR-T疗法JNJ-4528用于多发性骨髓瘤：86%的患者获得完全缓解

2020-12-22

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

GMP级慢病毒载体制备CAR-T细胞治疗之进展及未来

2021-04-10

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

AACR 2020：CAR-T治疗复发性或难治性(R/R)急性T淋巴细胞白血病试验初步结果公布

2020-11-11

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nat Med ：免疫疗法新突破！人体实验数据揭示CAR-NKT疗法治疗实体瘤的潜力

2021-03-20

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nat Med ：新型双CAR-T细胞疗法，快速清除体内HIV病毒，持久保护

2021-07-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

EXUMA公司的rPOC平台让CAR-T细胞治疗插上翅膀

2020-09-14

科室
- - 订阅+
  - 更多科室
工具
服务